                               SEQUENCE LISTING

<110> RAYZEBIO, INC.
 
<120> RADIOPHARMACEUTICAL CONJUGATE COMPOSITIONS AND USES THEREOF

<130> 59541-707.601

<140>
<141>

<150> 63/119,555
<151> 2020-11-30

<160> 12    

<170> PatentIn version 3.5

<210> 1
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (5)..(5)
<223> 2-aminoheptanoic acid

<220>
<221> MOD_RES
<222> (6)..(6)
<223> N-Methyl-Gly

<220>
<221> MOD_RES
<222> (8)..(8)
<223> N-Methyl-Phe

<220>
<221> MOD_RES
<222> (14)..(14)
<223> N-Methyl-Phe

<400> 1
Ala His Tyr Thr Xaa Gly Trp Phe Arg Val Arg Trp Tyr Phe Cys 
1               5                   10                  15  


<210> 2
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> N-Methyl-Phe

<220>
<221> MOD_RES
<222> (4)..(4)
<223> N-Methyl-Gly

<220>
<221> MOD_RES
<222> (8)..(8)
<223> N-Methyl-1-naphthylalanine

<400> 2
Phe Ser Trp Gly Tyr Asn Tyr Ala Gly Trp Trp Cys 
1               5                   10          


<210> 3
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (4)..(4)
<223> N-Methyl-Phe

<220>
<221> MOD_RES
<222> (9)..(9)
<223> N-Methyl-Tyr

<220>
<221> MOD_RES
<222> (10)..(10)
<223> N-Methyl-Tyr

<400> 3
Ala Arg Leu Phe Asp Tyr Asp Thr Tyr Tyr Trp Tyr Cys 
1               5                   10              


<210> 4
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (3)..(3)
<223> Cyclohexylglycine

<220>
<221> MOD_RES
<222> (4)..(4)
<223> N-Methyl-Phe

<220>
<221> MOD_RES
<222> (6)..(6)
<223> 3-chlorophenylalanine

<220>
<221> MOD_RES
<222> (9)..(9)
<223> N-Methyl-Tyr

<220>
<221> MOD_RES
<222> (10)..(10)
<223> N-Methyl-Tyr

<400> 4
Asp Arg Gly Phe Asp Phe Asp Thr Tyr Tyr Trp Tyr Cys 
1               5                   10              


<210> 5
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (3)..(3)
<223> Cyclohexylglycine

<220>
<221> MOD_RES
<222> (4)..(4)
<223> N-Methyl-Phe

<220>
<221> MOD_RES
<222> (9)..(9)
<223> N-Methyl-Tyr

<220>
<221> MOD_RES
<222> (10)..(10)
<223> N-Methyl-Tyr

<400> 5
Asp Arg Gly Phe Asp Tyr Asp Thr Tyr Tyr Trp Tyr Cys 
1               5                   10              


<210> 6
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (3)..(3)
<223> N-Methyl-Phe

<220>
<221> MOD_RES
<222> (7)..(7)
<223> N-Methyl-Tyr

<220>
<221> MOD_RES
<222> (10)..(10)
<223> N-Methyl-Tyr

<400> 6
Ala Ile Phe Tyr Asp Asp Tyr Tyr Asp Tyr Cys 
1               5                   10      


<210> 7
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (2)..(2)
<223> 3-phenylphenylalanine

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Cyclobutylalanine

<220>
<221> MOD_RES
<222> (10)..(10)
<223> 3-phenylphenylalanine

<400> 7
Trp Phe Asp Val Asp Ser Asp Ala Trp Phe Asp Cys 
1               5                   10          


<210> 8
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> N-Methyl-Phe

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Homophenylalanine

<400> 8
Phe Asp Asp Ser Val Trp Asp Phe Tyr Cys 
1               5                   10  


<210> 9
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (3)..(3)
<223> 3-chlorophenylalanine

<220>
<221> MOD_RES
<222> (7)..(7)
<223> N-Methyl-Phe

<220>
<221> MOD_RES
<222> (10)..(10)
<223> 6-chlorotryptaphan

<220>
<221> MOD_RES
<222> (12)..(12)
<223> N-Methyl-Gly

<220>
<221> MOD_RES
<222> (13)..(13)
<223> 2-aminoheptanoic acid

<400> 9
Ala Val Phe Tyr Arg Gly Phe Thr Gly Xaa Val Gly Xaa Cys 
1               5                   10                  


<210> 10
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> 18F-Lys

<400> 10
Lys Tyr Asn Asp Arg Leu Pro Leu Tyr Ile Ser Asn Pro 
1               5                   10              


<210> 11
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 11
Glu Ala Ala Ala Lys 
1               5   


<210> 12
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (2)..(2)
<223> Ile or Thr

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Ala or Glu

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Ala, Asp, Val, or Gly

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 12
Phe Xaa Asp Asp Tyr Gly Ile Thr Asp Tyr Asp Xaa Xaa Cys 
1               5                   10                  


